Healthcare Industry News:  Procter & Gamble 

Biopharmaceuticals Litigation

 News Release - August 31, 2006

P&G and Cumberland Swan Holdings Reach Settlement Agreement

CINCINNATI, Aug. 31, 2006 (HSMN NewsFeed) -- The Procter & Gamble Company (NYSE: PG ) has reached a settlement in the lawsuit it filed on May 2, 2006 against Cumberland Swan Holdings, Inc. for trade dress infringement and false advertising of its Crest Pro-Health® oral rinse brand. Cumberland Swan denied those contentions, but has agreed to a Consent Judgment and will stop manufacturing, distributing and selling the infringing products. The remaining terms of the agreement were not disclosed.

"This case was about consumers being misled into believing that they were buying products comparable to Crest Pro-Health," said Jim Johnson, P&G's chief legal officer. "We're satisfied that Cumberland Swan must now compete with its own designs and substantiate its performance claims with meaningful testing, as we do," added Johnson.

About Procter & Gamble

Three billion times a day, P&G brands touch the lives of people around the world. The company has one of the strongest portfolios of trusted, quality, leadership brands, including Pampers®, Tide®, Ariel®, Always®, Whisper®, Pantene®, Mach3®, Bounty®, Dawn®, Pringles®, Folgers®, Charmin®, Downy®, Lenor®, Iams®, Crest®, Oral-B®, Actonel®, Duracell®, Olay®, Head & Shoulders®, Wella®, Gillette®, and Braun®. The P&G community consists of over 135,000 employees working in over 80 countries worldwide. Please visit http://www.pg.com for the latest news and in-depth information about P&G and its brands.


Source: Procter & Gamble

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.